Cancer discovery could revive failed treatments for solid tumors
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials. The research from UVA’s Jogender Tushir-Singh explains why antibody approaches effectively killed cancer tumors in lab tests, but proved ineffective in people. He found […]
Continue Reading